News tagged with her2 receptor

New radiation-free targeted therapy detects and eliminates breast cancer tumors in mice

Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, ...

Medicine & Health / Cancer

created Mar 30, 2009 | popularity 5 / 5 (1) | comments 0

Researchers use light to measure cancer cells' response to treatment

Many cancer therapies target specific proteins that proliferate on the outside of some cancer cells, but the therapies are imperfect and the cancer does not always respond. Since it is beneficial for doctors to know as soon ...

Physics / Optics & Photonics

created Dec 20, 2011 | popularity 5 / 5 (1) | comments 0

Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?

A research team from Germany analyzed the pathogenetic role and potential clinical usefulness of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2) in patients with advanced ...

Medicine & Health / Cancer

created Oct 16, 2009 | popularity not rated yet | comments 0

Fox Chase clinical trial tests first of its kind antibody

Patients with HER2-positive cancers can have dramatic responses to HER2-targeted drugs but eventually develop resistance to the agents. With that problem in mind, Fox Chase Cancer Center researchers are testing a novel type ...

Medicine & Health / Cancer

created Jun 04, 2010 | popularity not rated yet | comments 0

Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies

An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.

Medicine & Health / Cancer

created May 06, 2010 | popularity not rated yet | comments 0

Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer

Fox Chase Cancer Center researchers report that a combination of trastuzumab and neratinib (HKI-272) a novel small molecule inhibitor of the HER2 receptor (ErbB2) appears active in women with HER2-positive metastatic breast ...

Medicine & Health / Cancer

created May 28, 2009 | popularity not rated yet | comments 0

African-American women with advanced breast cancer often forego vital treatment

A new study finds that nearly one in four African American women with late stage breast cancer refused chemotherapy and radiation therapy, potentially life saving therapies. Published in the July 1, 2009 issue of Cancer, a peer ...

Medicine & Health / Cancer

created May 22, 2009 | popularity not rated yet | comments 1